erlotinib has been researched along with ver 52296 in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (ver 52296) | Trials (ver 52296) | Recent Studies (post-2010) (ver 52296) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 43 | 0 | 38 |
| Protein | Taxonomy | erlotinib (IC50) | ver 52296 (IC50) |
|---|---|---|---|
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | 0.0587 | |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | 0.0658 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.008 | |
| Endoplasmin | Homo sapiens (human) | 0.085 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.008 | |
| Endoplasmin | Canis lupus familiaris (dog) | 0.012 | |
| Heat shock protein 75 kDa, mitochondrial | Homo sapiens (human) | 0.3577 | |
| Histidine kinase | Caulobacter vibrioides | 7.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for erlotinib and ver 52296
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |